Ruth Mckernan serves as Executive at Cerevel Therapeutics Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Ruth Mckernan has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 1, 2024 involved selling 10,461 shares valued at $0.
Ruth Mckernan currently holds 10,461 shares of Cerevel Therapeutics Holdings, Inc. (CERE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ruth Mckernan has been a net neutral trader of CERE stock. They have purchased $0 and sold $0 worth of shares.
Ruth Mckernan's most recent insider trade was on Aug 1, 2024, when they sold 10,461 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 5, 2024 | CERE | $0 | Award | 10,461 | $N/A | Discretionary |
| Jun 7, 2023 | CERE | $0 | Award | 3,282 | $N/A | Discretionary |